# Conbercept Injection in Treatment of Severe Proliferative Diabetic Retinopathy

> **NCT02816710** · PHASE4 · COMPLETED · sponsor: **Ruijin Hospital** · enrollment: 112 (actual)

## Conditions studied

- Proliferative Diabetic Retinopathy
- Tractional Retinal Detachment

## Interventions

- **DRUG:** Conbercept

## Key facts

- **NCT ID:** NCT02816710
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2017-09
- **Final completion:** 2017-09
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2019-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02816710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02816710, "Conbercept Injection in Treatment of Severe Proliferative Diabetic Retinopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02816710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*